Volume 26, Issue 1 (Avicenna Journal of Clinical Medicine-Spring 2019)
Avicenna J Clin Med 2019, 26(1): 60-66 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fariba F, Jiryaee N, Neshatyar C, Tarbiat M. Evaluation of the Frequency of Risk Factors in Venous Thromboembolic Patients Admitted to Ekbatan and Farshchian Hospitals in Hamadan from 2012 to 2017. Avicenna J Clin Med 2019; 26 (1) :60-66
URL: http://sjh.umsha.ac.ir/article-1-1869-en.html
URL: http://sjh.umsha.ac.ir/article-1-1869-en.html
1- , n_jiryaee@yahoo.com
Abstract: (3089 Views)
Background and Objective: Venous thromboembolism is one of the major causes of mortality worldwide. Various environmental and genetic factors are known as risk factors for this disease. Therefore, this study aimed to investigate the frequency of risk factors in patients with venous thromboembolism admitted to Ekbatan and Farshchian hospitals in Hamadan from 2012 to 2017.
Materials and Methods: This cross-sectional descriptive study investigated all patients with venous thromboembolism who had medical records regarding risk factors of venous thromboembolism using census sampling method. The obtained data were analyzed in SPSS software (Version 21).
Results: According to the results, out of 226 patients under study, 116 (51.3%) ones were male. Moreover, 103 (45.6%), 76 (33.6%), and 47 (20.8%) patients had deep venous thrombosis, pulmonary embolism, and severe lung embolism with deep venous thrombosis, respectively. The mean±SD age of patients was 59.15±19.85 years. Moreover, the most frequent risk factors associated with venous thromboembolism include the history of hypertension (37.2%), recent hospitalization (29.6%), cardiovascular problems (27.5%), history of recent surgery (16.8%), history of intravenous thromboembolism (8.8% 16%), history of smoking (16.8%), statin use (15.5%), history of hyperlipidemia (13.7%), and catheterization (13.7%).
Conclusion: Venous thromboembolism is a multifactorial disease in which some risk factors contribute to the increased risk of it directly and indirectly.
Materials and Methods: This cross-sectional descriptive study investigated all patients with venous thromboembolism who had medical records regarding risk factors of venous thromboembolism using census sampling method. The obtained data were analyzed in SPSS software (Version 21).
Results: According to the results, out of 226 patients under study, 116 (51.3%) ones were male. Moreover, 103 (45.6%), 76 (33.6%), and 47 (20.8%) patients had deep venous thrombosis, pulmonary embolism, and severe lung embolism with deep venous thrombosis, respectively. The mean±SD age of patients was 59.15±19.85 years. Moreover, the most frequent risk factors associated with venous thromboembolism include the history of hypertension (37.2%), recent hospitalization (29.6%), cardiovascular problems (27.5%), history of recent surgery (16.8%), history of intravenous thromboembolism (8.8% 16%), history of smoking (16.8%), statin use (15.5%), history of hyperlipidemia (13.7%), and catheterization (13.7%).
Conclusion: Venous thromboembolism is a multifactorial disease in which some risk factors contribute to the increased risk of it directly and indirectly.
Type of Study: Original |
Subject:
Cardiovascular Diseases
References
1. Puurunen MK, Gona PN, Larson MG, Murabito JM, Magnani JW, O'Donnell CJ. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res. 2016;145:27-33. PMID: 27442716 DOI: 10.1016/j.thromres.2016.06.033
2. Cohoon KP, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is infection an independent risk factor for venous thromboembolism? A population-based, case-control study. Am J Med. 2018;131(3):307-16. PMID: 28987552 DOI: 10.1016/j.amjmed.2017.09.015
3. Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailey KR. Effect of near-universal hospitalization-based prophylaxis on annual number of venous thromboembolism events in the US. Blood. 2017;130(2):109-14. PMID: 28483763 DOI: 10.1182/blood-2016-12-758995
4. Farzamnia H, Rabiei K, Sadeghi M, Roghani F. The predictive factors of recurrent deep vein thrombosis. ARYA Atheroscler. 2011;7(3):123-8. PMID: 22577459
5. Heit JA. Epidemiology of venous thromboembolism. Nature Rev Cardiol. 2015;12(8):464-74. PMID: 26076949 DOI: 10.1038/nrcardio.2015.83
6. ChendrasekharA, Aleti S. Venous thromboembolism risk assessments on trauma patients has suboptimal interobserver reliability among inexperienced clinicians (fourth-year medical students). Int J Gen Med. 2018;11:225-31. PMID: 29950883 DOI: 10.2147/IJGM.S162025
7. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Int Med. 1999;159(5):445-53. PMID: 10074952
8. Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016;42(8):808-20. PMID: 27764878 DOI: 10.1055/s-0036-1592333
9. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56(1):1-7. PMID: 20620709 DOI: 10.1016/j.jacc.2010.01.057
10. Rosendal FR. Causes of venous thrombosis. Thromb J. 2016;14(1):24. PMID: 27766050 DOI: 10.1186/s12959-016-0108-y
11. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24):1601-6. PMID: 7969340 DOI: 10.1056/NEJM199412153312401
12. Ghasemieh J, Rezaeetalab F. Evaluation of the clinical features, diagnostic procedures and mortality of acute pulmonary thromboembolism pulmonary and Ttuberculosis Research Center, Mashhad of Medical Sciences University. Med J Mashhad Univ Med Sci. 2008;51(2):115-20. [Persian]
13. Kazemi T, Qasemi M, Taghavi SM. Epidemiologic study of patients with DVT in Birjand Vali-Easr hospital-(2009-2014). J Birjand Univ Med Sci. 2016;23(1):1-6. [Persian]
14. Ghaffary MR, Ansarin K, Sakhinia E, Khoramifar AR. Thrombophilia and biological fat of pulmonary embolism. Razi J Med Sci. 2013;20(108):70-7. [Persian]
15. Aghazade M, Hariri Ardabili A, Peirzade AM. The prevalence of blood groups in patients with deep vein thrombosis and pulmonary embolism. [Doctoral Dissertation]. Ardabil, Iran: Ardabil University of Medical Sciences; 2012. [Persian]
16. Nagamalesh UM, Prakash VS, Naidu KC, Sarthak S, Hegde AV, Abhinay T. Acute pulmonary thromboembolism: Epidemiology, predictors, and long-term outcome. A single center experience. Indian Heart J. 2017;69(2):160-4. PMID: 28460762 DOI: 10.1016/j.ihj.2016.08.010
17. Mi Y, Yan S, Lu Y, Liang Y, Li C. Venous thromboembolism has the same risk factors as atherosclerosis: a PRISMA-compliant systemic review and meta-analysis. Medicine. 2016;95(32):e4495. PMID: 27512866 DOI: 10.1097/MD.0000000000004495
18. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e195S-e226S. PMID: 22315261 DOI: 10.1378/chest.11-2296
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
